Real-World Study on Chinese Medicine for Treating Chikungunya Fever
Efficacy and Safety of Chinese Medicine in the Treatment of Chikungunya Fever: A Real-World Observational Study
Guangzhou University of Traditional Chinese Medicine
600 participants
Jul 26, 2025
OBSERVATIONAL
Conditions
Summary
This study aims to evaluate the effectiveness and safety of Chinese Medicine-used alone or combined with Western medicine-in treating chikungunya fever, a mosquito-borne viral disease causing fever, rash, and severe joint pain. With recent outbreaks in China (including over 3,000 cases in Foshan, Guangdong) and no specific antiviral treatment available, Chinese medicine may offer a valuable therapeutic option based on its symptom-relief and syndrome-specific approach.
Eligibility
Inclusion Criteria4
- Meets the suspected or confirmed diagnostic criteria for chikungunya fever;
- Symptom onset ≤3 days before enrollment;
- Actual prescribed treatment aligns with the study's group assignment (TCM, Western medicine, or combined therapy)
- Signed informed consent form
Exclusion Criteria3
- Severe chikungunya fever;
- Participation in another drug clinical trial within the past 3 months;
- Any other condition deemed by the investigator as unsuitable for enrollment.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07120724